HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer

NCT04523896 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER_GOV

Sponsor class

Conditions

Prostatic Neoplasm

Interventions

RADIATION: Real time High-Dose-Rate prostate brachytherapy in combination with stereotactic prostate radiotherapy

Sponsor

David Büchser